Geode Capital Management
TNYA icon

Geode Capital Management’s Tenaya Therapeutics TNYA Stock Holding History

Geode Capital Management’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36M Buy
1,834,674
+274,735
+18% +$209K ﹤0.01% 3282
2026
Q1 		$1.08M Buy
1,559,939
+366,584
+31% +$271K ﹤0.01% 3340
2025
Q4 		$849K Buy
1,193,355
+17,820
+2% +$24.2K ﹤0.01% 3424
2025
Q3 		$1.91M Sell
1,175,535
-55,059
-4% -$55.5K ﹤0.01% 3193
2025
Q2 		$752K Sell
1,230,594
-144,587
-11% -$73.6K ﹤0.01% 3422
2025
Q1 		$784K Buy
1,375,181
+106,444
+8% +$105K ﹤0.01% 3389
2024
Q4 		$1.81M Sell
1,268,737
-27,419
-2% -$61.5K ﹤0.01% 3166
2024
Q3 		$2.5M Buy
1,296,156
+66,968
+5% +$189K ﹤0.01% 3055
2024
Q2 		$3.81M Buy
1,229,188
+189,142
+18% +$781K ﹤0.01% 2871
2024
Q1 		$5.44M Buy
1,040,046
+111,283
+12% +$532K ﹤0.01% 2652
2023
Q4 		$3.01M Buy
928,763
+55,550
+6% +$120K ﹤0.01% 2946
2023
Q3 		$2.23M Buy
873,213
+53,641
+7% +$225K ﹤0.01% 3040
2023
Q2 		$4.81M Buy
819,572
+28,782
+4% +$167K ﹤0.01% 2699
2023
Q1 		$2.25M Buy
790,790
+315,046
+66% +$885K ﹤0.01% 2973
2022
Q4 		$956K Buy
475,744
+25,836
+6% +$63.1K ﹤0.01% 3360
2022
Q3 		$1.3M Buy
449,908
+69,267
+18% +$323K ﹤0.01% 3265
2022
Q2 		$2.14M Buy
380,641
+12,424
+3% +$101K ﹤0.01% 3089
2022
Q1 		$4.34M Buy
368,217
+139,078
+61% +$1.68M ﹤0.01% 2877
2021
Q4 		$4.34M Buy
229,139
+13,176
+6% +$287K ﹤0.01% 2972
2021
Q3 		$4.46M Buy
+215,963
New +$4.64M ﹤0.01% 2972

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Geode Capital Management's TNYA Position: Q2 2026 in Review

Geode Capital Management increased its Tenaya Therapeutics (TNYA) stake by 18% in Q2 2026, buying an estimated $209K and bringing the position to 1,834,674 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #3282.

Geode Capital Management first reported a position in TNYA in Q3 2021 and has held it in 20 quarters since. The position peaked at $5.44M in Q1 2024. 98 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Geode Capital Management held 1,834,674 shares of Tenaya Therapeutics worth $1.36M as of Q2 2026.
  • Geode Capital Management bought 274,735 Tenaya Therapeutics shares in Q2 2026, an estimated $209K.
  • Tenaya Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3282 holding.
  • Geode Capital Management first reported a position in Tenaya Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • Geode Capital Management's Tenaya Therapeutics position peaked at $5.44M in Q1 2024.
  • 98 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.